AngioDynamics Reports Fiscal 2020 Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
AngioDynamics (ANGO) Tops Q2 EPS by 4c, Revenues Miss; Offers FY20 EPS/Revenue Outlook
January 7, 2020 7:04 AM ESTAngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $70 million versus the consensus estimate of $71.28 million.
Net sales of $70.0 million, flat compared to the prior-year quarterGross margin increased 140 basis points year over year to 59.3%GAAP loss per share... More